Ipamorelin

Why Researchers Choose Ipamorelin

Ipamorelin is the most receptor-selective GH secretagogue available for metabolic and recovery research, and it is studied wherever a clean growth hormone pulse is needed without confounding cortisol or prolactin signals:

• Selective GHS-R1a receptor pharmacology and GH-axis investigations
• Pulsatile GH secretion and natural secretory-rhythm modelling
• IGF-1 driven muscle protein synthesis and recovery protocols
• Body composition and lean-mass research with minimal water retention
• GH and sleep architecture studies (slow-wave sleep enhancement)
• Synergistic secretagogue stacking with GHRH analogues such as CJC-1295

How Ipamorelin Works: GHS-R1a Selectivity

Ipamorelin binds the ghrelin receptor (GHS-R1a) on somatotrophs in the anterior pituitary with high affinity. The receptor is Gq-coupled: activation drives phospholipase C, raises intracellular calcium and triggers exocytosis of stored GH secretory granules.

The selectivity is what sets it apart. Older secretagogues like GHRP-2 and GHRP-6 also engage corticotropin-releasing-hormone (CRH) pathways, which elevate ACTH and cortisol. Ipamorelin’s binding profile is essentially restricted to GHS-R1a, so it releases growth hormone with little to no cortisol or prolactin spillover. The result is a discrete, pulsatile GH pulse that mirrors natural physiology rather than continuous elevation, which helps preserve receptor sensitivity.

Combination with CJC-1295

Ipamorelin (GHS-R1a agonist) and CJC-1295 (GHRH receptor agonist) act through entirely different receptors that converge on the same pituitary somatotrophs:

• GHRH receptor activation (CJC-1295) raises cAMP via Gs coupling, priming the cell for GH release.
• GHS-R1a activation (ipamorelin) raises intracellular calcium via Gq coupling, triggering secretory granule fusion.

Used together they produce a synergistic GH release substantially greater than the additive effect of each alone. See the CJC-1295 + Ipamorelin Combo for the paired protocol.

Downstream Effects of Pulsatile GH Release

Each GH pulse from ipamorelin drives hepatic IGF-1 production, the mediator of most of its anabolic and recovery effects:

• Muscle protein synthesis via mTOR activation
• Fat mobilisation via hormone-sensitive lipase (HSL) activation and reduced lipogenesis
• Deeper sleep via GH-driven slow-wave sleep enhancement
• Connective-tissue maintenance via stimulated collagen synthesis

Reconstitution and Storage

Reconstitution: use bacteriostatic water; swirl gently until dissolved, do not shake. After reconstitution: keep refrigerated (2-8°C) and protected from light; use within 30 days.

For research purposes only. Not for human consumption.